Possible influence of granulocyte colony-stimulating factor and recombinant human erythropoietin on human chorionic gonadotropin secretion during chemotherapy for choriocarcinoma.
Lösch
A
A
Lahodny
J
J
Petru
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000601:surgery; D006063:Chorionic Gonadotropin / Q000378:metabolism*; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology* / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011994:Recombinant Proteins; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery
D006063:Chorionic Gonadotropin; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor